Home / Stocks / CAI

CAI insider trading

Caris Life Sciences, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
6
Bought · 24 mo
$2.4M
Buys · last 90 days
1 · $990k
Most recent buy
2026-07-13

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-07-13HALBERT JON
Director
Bought68,000$14.56$990k
2026-05-12Vacirca Jeff L
Director
Bought31,050$16.15$501k
2025-12-12Power Luke Thomas
See Remarks
Sold60,850$26.56$1.6M
2025-11-10Denton John Russel
See Remarks
Bought4,184$24.09$101k
2025-11-10Spetzler David Baxley
President
Bought400$23.85$10k
2025-06-23Denton John Russel
See Remarks
Bought7,500$21.00$158k
2025-06-23Brille Brian J
See Remarks
Bought30,000$21.00$630k

Most active insider buyers

InsiderRoleBuysTotal bought
HALBERT JONDirector1$990k
Brille Brian JSee Remarks1$630k
Vacirca Jeff LDirector1$501k
Denton John RusselSee Remarks2$258k
Spetzler David BaxleyPresident1$10k

See CAI on the chart

Every insider buy and sell for CAI plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.